Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.894
-0.002 (-0.18%)
At close: Jan 17, 2025, 4:00 PM
0.890
-0.004 (-0.44%)
After-hours: Jan 17, 2025, 7:00 PM EST
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $17.27 million as of January 17, 2025. Its market cap has decreased by -64.72% in one year.
Market Cap
17.27M
Enterprise Value
24.39M
1-Year Change
-64.72%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $17.27M, a decrease of -93.69%. That is a compound annual growth rate of -57.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 17.27M | -22.27% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |